Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Outflanking immunodominance to target subdominant broadly neutralizing epitopes.

Angeletti D, Kosik I, Santos JJS, Yewdell WT, Boudreau CM, Mallajosyula VVA, Mankowski MC, Chambers M, Prabhakaran M, Hickman HD, McDermott AB, Alter G, Chaudhuri J, Yewdell JW.

Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13474-13479. doi: 10.1073/pnas.1816300116. Epub 2019 Jun 18.

PMID:
31213541
2.

Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines.

Sutton TC, Chakraborty S, Mallajosyula VVA, Lamirande EW, Ganti K, Bock KW, Moore IN, Varadarajan R, Subbarao K.

NPJ Vaccines. 2017 Dec 15;2:35. doi: 10.1038/s41541-017-0036-2. eCollection 2017.

3.

Neutralization and Binding Profile of Monoclonal Antibodies Generated Against Influenza A H1N1 Viruses.

Shembekar N, Mallajosyula VV, Malik A, Saini A, Varadarajan R, Gupta SK.

Monoclon Antib Immunodiagn Immunother. 2016 Aug;35(4):191-8. doi: 10.1089/mab.2016.0015. Epub 2016 Jul 27.

PMID:
27463230
4.

Stalking influenza by vaccination with pre-fusion headless HA mini-stem.

Valkenburg SA, Mallajosyula VV, Li OT, Chin AW, Carnell G, Temperton N, Varadarajan R, Poon LL.

Sci Rep. 2016 Mar 7;6:22666. doi: 10.1038/srep22666.

5.

Generation and Characterization of Monoclonal Antibodies Specific to Avian Influenza H5N1 Hemagglutinin Protein.

Malik A, Mallajosyula VV, Mishra NN, Varadarajan R, Gupta SK.

Monoclon Antib Immunodiagn Immunother. 2015 Dec;34(6):436-41. doi: 10.1089/mab.2015.0047.

PMID:
26683184
6.

Hemagglutinin Sequence Conservation Guided Stem Immunogen Design from Influenza A H3 Subtype.

Mallajosyula VV, Citron M, Ferrara F, Temperton NJ, Liang X, Flynn JA, Varadarajan R.

Front Immunol. 2015 Jun 26;6:329. doi: 10.3389/fimmu.2015.00329. eCollection 2015.

7.

Humanized antibody neutralizing 2009 pandemic H1N1 virus.

Shembekar N, Mallajosyula VV, Chaudhary P, Upadhyay V, Varadarajan R, Gupta SK.

Biotechnol J. 2014 Dec;9(12):1594-603. doi: 10.1002/biot.201400083. Epub 2014 Aug 8.

PMID:
25044602
8.

Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection.

Mallajosyula VV, Citron M, Ferrara F, Lu X, Callahan C, Heidecker GJ, Sarma SP, Flynn JA, Temperton NJ, Liang X, Varadarajan R.

Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):E2514-23. doi: 10.1073/pnas.1402766111. Epub 2014 Jun 9.

9.

Immunogen design for HIV-1 and influenza.

Rathore U, Kesavardhana S, Mallajosyula VV, Varadarajan R.

Biochim Biophys Acta. 2014 Nov;1844(11):1891-1906. doi: 10.1016/j.bbapap.2014.05.010. Epub 2014 Jun 2. Review.

PMID:
24892211
10.

In vitro and in vivo characterization of designed immunogens derived from the CD-helix of the stem of influenza hemagglutinin.

Mallajosyula VV, Citron M, Lu X, Meulen JT, Varadarajan R, Liang X.

Proteins. 2013 Oct;81(10):1759-75. doi: 10.1002/prot.24317. Epub 2013 Jul 23.

PMID:
23625724
11.

Isolation of a high affinity neutralizing monoclonal antibody against 2009 pandemic H1N1 virus that binds at the 'Sa' antigenic site.

Shembekar N, Mallajosyula VV, Mishra A, Yeolekar L, Dhere R, Kapre S, Varadarajan R, Gupta SK.

PLoS One. 2013;8(1):e55516. doi: 10.1371/journal.pone.0055516. Epub 2013 Jan 31.

Supplemental Content

Loading ...
Support Center